New Zealand - English - Medsafe (Medicines Safety Authority)

takeda new zealand limited - rurioctocog alfa pegol 1000 [iu];  ;   - powder for injection with diluent - 1000 iu - active: rurioctocog alfa pegol 1000 [iu]     excipient: calcium chloride dihydrate glutathione histidine mannitol polysorbate 80 sodium chloride trehalose dihydrate trometamol water for injection - adynovate is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia a (congenital factor viii deficiency) patients for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis) adynovate is not indicated for the treatment of von willebrand disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

takeda new zealand limited - rurioctocog alfa pegol 2000 [iu];  ;   - powder for injection with diluent - 2000 iu - active: rurioctocog alfa pegol 2000 [iu]     excipient: calcium chloride dihydrate glutathione histidine mannitol polysorbate 80 sodium chloride trehalose dihydrate trometamol water for injection - adynovate is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia a (congenital factor viii deficiency) patients for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis) adynovate is not indicated for the treatment of von willebrand disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

takeda new zealand limited - rurioctocog alfa pegol 250 [iu];  ;   - powder for injection with diluent - 250 iu - active: rurioctocog alfa pegol 250 [iu]     excipient: calcium chloride dihydrate glutathione histidine mannitol polysorbate 80 sodium chloride trehalose dihydrate trometamol water for injection - adynovate is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia a (congenital factor viii deficiency) patients for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis) adynovate is not indicated for the treatment of von willebrand disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

takeda new zealand limited - rurioctocog alfa pegol 500 [iu];  ;   - powder for injection with diluent - 500 iu - active: rurioctocog alfa pegol 500 [iu]     excipient: calcium chloride dihydrate glutathione histidine mannitol polysorbate 80 sodium chloride trehalose dihydrate trometamol water for injection - adynovate is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia a (congenital factor viii deficiency) patients for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis) adynovate is not indicated for the treatment of von willebrand disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

takeda new zealand limited - rurioctocog alfa pegol 1500 [iu];  ;   - powder for injection with diluent - 1500 iu - active: rurioctocog alfa pegol 1500 [iu]     excipient: calcium chloride dihydrate glutathione histidine mannitol polysorbate 80 sodium chloride trehalose dihydrate trometamol water for injection - adynovate is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia a (congenital factor viii deficiency) patients for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis) adynovate is not indicated for the treatment of von willebrand disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

takeda new zealand limited - rurioctocog alfa pegol 3000 [iu];  ;   - powder for injection with diluent - 3000 iu - active: rurioctocog alfa pegol 3000 [iu]     excipient: calcium chloride dihydrate glutathione histidine mannitol polysorbate 80 sodium chloride trehalose dihydrate trometamol water for injection - adynovate is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia a (congenital factor viii deficiency) patients for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis) adynovate is not indicated for the treatment of von willebrand disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

takeda new zealand limited - rurioctocog alfa pegol 750 [iu];  ;   - powder for injection with diluent - 750 iu - active: rurioctocog alfa pegol 750 [iu]     excipient: calcium chloride dihydrate glutathione histidine mannitol polysorbate 80 sodium chloride trehalose dihydrate trometamol water for injection - adynovate is a long-acting antihaemophilic factor (recombinant) indicated in haemophilia a (congenital factor viii deficiency) patients for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis) adynovate is not indicated for the treatment of von willebrand disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - betamethasone valerate 0.122%{relative} equivalent to 0.1% betamethasone - lotion - 0.1 % - active: betamethasone valerate 0.122%{relative} equivalent to 0.1% betamethasone excipient: cetomacrogol 1000 cetostearyl alcohol citric acid monohydrate glycerol isopropyl alcohol liquid paraffin methyl hydroxybenzoate purified water sodium citrate dihydrate xanthan gum - betnovate lotion is a potent topical corticosteroid indicated foradults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses. these include the following: ·atopic dermatitis (including infantileatopic dermatitis) ·nummular dermatitis (discoid eczema) ·prurigo nodularis ·psoriasis (excluding widespread plaque psoriasis) ·lichen simplex chronicus (neurodermatitis) and lichen planus ·seborrhoeic dermatitis ·irritant or allergic contact dermatitis ·discoid lupus erythematosus ·insect bite reactions ·miliaria (prickly heat); and ·adjunct to systemic steroid therapy in generalised erythroderma.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - betamethasone as valerate - solution - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - steroid responsive dermatoses of the scalp, such as psoriasis, seborrheic capitis and inflammation associated with severe dandruff.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.61 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: liquid paraffin; white soft paraffin - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.